{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:42:48Z","timestamp":1785811368104,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anti-glomerular basement membrane (anti-GBM) disease is characterized by crescentic necrotizing glomerulonephritis, with linear deposits of immunoglobulin G (IgG) in the GBM. Classic anti-GBM disease is clinically associated with rapidly progressive glomerulonephritis with or without pulmonary hemorrhage. Some patients have a better renal prognosis and milder symptoms than those with classic anti-GBM disease, which is termed atypical anti-GBM disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 43-year-old Japanese woman was admitted to our hospital complaining of hematuria that had persisted for more than one month. Serological examination revealed negativity for anti-nuclear, anti-neutrophilic cytoplasmic, and anti-GBM antibodies. However, renal biopsy showed cellular crescents. Immunofluorescence revealed strong diffuse linear capillary loop staining for IgG. An indirect immunofluorescence antibody method was performed by applying the patient serum to normal kidney tissue to confirm the presence of autoantibodies binding to the GBM. Using this method, anti-GBM antibodies were detected. The patient was treated with high-dose steroids, cyclophosphamide, and plasma exchange. Aggressive treatment resolved proteinuria and hematuria and improved renal function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Renal biopsy is crucial in the diagnosis of anti-GBM disease, especially when serological tests are negative. Accurately identifying the presence of anti-GBM disease is important to initiate optimal treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-03007-y","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T07:03:09Z","timestamp":1668841389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A case report of atypical anti-glomerular basement membrane disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Ryo","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuma","family":"Hirashio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinari","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4271-9964","authenticated-orcid":false,"given":"Takao","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"3","key":"3007_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1309\/NPTP4UKV7JU3ELMQ","volume":"125","author":"EG Fischer","year":"2006","unstructured":"Fischer EG, Lager DJ. Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am J Clin Pathol. 2006;125(3):445\u201350.","journal-title":"Am J Clin Pathol."},{"issue":"26","key":"3007_CR2","doi-asserted-by":"publisher","first-page":"13374","DOI":"10.1016\/S0021-9258(18)37714-7","volume":"263","author":"J Saus","year":"1988","unstructured":"Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem. 1988;263(26):13374\u201380.","journal-title":"J Biol Chem."},{"issue":"3","key":"3007_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/ki.1994.338","volume":"46","author":"T Hellmark","year":"1994","unstructured":"Hellmark T, Johansson C, Wieslander J. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int. 1994;46(3):823\u20139.","journal-title":"Kidney Int."},{"issue":"6","key":"3007_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s10157-009-0201-7","volume":"13","author":"A Koyama","year":"2009","unstructured":"Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13(6):633\u201350.","journal-title":"Clin Exp Nephrol."},{"issue":"3","key":"3007_CR5","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","volume":"63","author":"JC Jennette","year":"2003","unstructured":"Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63(3):1164\u201377.","journal-title":"Kidney Int."},{"issue":"4","key":"3007_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5414\/CNP67240","volume":"67","author":"K Benz","year":"2007","unstructured":"Benz K, Amann K, Dittrich K, Hugo C, Schnur K, D\u00f6tsch J. Patient with antibody-negative relapse of Goodpasture syndrome. Clin Nephrol. 2007;67(4):240\u20134.","journal-title":"Clin Nephrol."},{"issue":"6","key":"3007_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/ckj\/sfs107","volume":"5","author":"A Kussman","year":"2012","unstructured":"Kussman A, Gohara A. Serum antibody-negative Goodpasture syndrome with delta granule pool storage deficiency and eosinophilia. Clin Kidney J. 2012;5(6):572\u20135.","journal-title":"Clin Kidney J."},{"issue":"4","key":"3007_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.kint.2016.02.001","volume":"89","author":"SH Nasr","year":"2016","unstructured":"Nasr SH, Collins AB, Alexander MP, Schraith DF, Herrera Hernandez L, Fidler ME, et al. The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. Kidney Int. 2016;89(4):897\u2013908.","journal-title":"Kidney Int."},{"issue":"1","key":"3007_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/jclinpath-2018-205278","volume":"72","author":"D Liang","year":"2019","unstructured":"Liang D, Liang S, Xu F, Zhang M, Li X, Tu Y, et al. Clinicopathological features and outcome of antibody-negative anti-glomerular basement membrane disease. J Clin Pathol. 2019;72(1):31\u20137.","journal-title":"J Clin Pathol."},{"key":"3007_CR10","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3389\/fimmu.2020.02035","volume":"11","author":"CR Shen","year":"2020","unstructured":"Shen CR, Jia XY, Cui Z, Yu XJ, Zhao MH. Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort. Front Immunol. 2020;11:2035.","journal-title":"Front Immunol."},{"issue":"4","key":"3007_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.rdc.2018.06.011","volume":"44","author":"K Gulati","year":"2018","unstructured":"Gulati K, McAdoo SP. Anti-Glomerular Basement Membrane Disease. Rheum Dis Clin North Am. 2018;44(4):651\u201373.","journal-title":"Rheum Dis Clin North Am."},{"issue":"11","key":"3007_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","volume":"134","author":"JB Levy","year":"2001","unstructured":"Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134(11):1033\u201342.","journal-title":"Ann Intern Med."},{"issue":"5","key":"3007_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/MD.0b013e31822f6f68","volume":"90","author":"Z Cui","year":"2011","unstructured":"Cui Z, Zhao J, Jia XY, Zhu SN, Jin QZ, Cheng XY, et al. Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine (Baltimore). 2011;90(5):303\u201311.","journal-title":"Medicine (Baltimore)."},{"issue":"6","key":"3007_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1084\/jem.126.6.989","volume":"126","author":"RA Lerner","year":"1967","unstructured":"Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967;126(6):989\u20131004.","journal-title":"J Exp Med."},{"issue":"16","key":"3007_CR15","doi-asserted-by":"publisher","first-page":"11267","DOI":"10.1074\/jbc.274.16.11267","volume":"274","author":"KO Netzer","year":"1999","unstructured":"Netzer KO, Leinonen A, Boutaud A, Borza DB, Todd P, Gunwar S, et al. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17\u201331 and 127\u2013141 of the NC1 domain. J Biol Chem. 1999;274(16):11267\u201374.","journal-title":"J Biol Chem."},{"issue":"8","key":"3007_CR16","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1074\/jbc.275.8.6030","volume":"275","author":"DB Borza","year":"2000","unstructured":"Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J, et al. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem. 2000;275(8):6030\u20137.","journal-title":"J Biol Chem."},{"issue":"4","key":"3007_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJMoa0910500","volume":"363","author":"V Pedchenko","year":"2010","unstructured":"Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010;363(4):343\u201354.","journal-title":"N Engl J Med."},{"issue":"11","key":"3007_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.autrev.2013.06.014","volume":"12","author":"F Dammacco","year":"2013","unstructured":"Dammacco F, Battaglia S, Gesualdo L, Racanelli V. Goodpasture's disease: a report of ten cases and a review of the literature. Autoimmun Rev. 2013;12(11):1101\u20138.","journal-title":"Autoimmun Rev."},{"issue":"6","key":"3007_CR19","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/ndt\/gfn761","volume":"24","author":"R Yang","year":"2009","unstructured":"Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, et al. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant. 2009;24(6):1838\u201344.","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"3007_CR20","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.4049\/jimmunol.1202204","volume":"190","author":"F Olaru","year":"2013","unstructured":"Olaru F, Wang XP, Luo W, Ge L, Miner JH, Kleinau S, et al. Proteolysis breaks tolerance toward intact \u03b1345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for \u03b1345NC1 hexamers. J Immunol. 2013;190(4):1424\u201332.","journal-title":"J Immunol."},{"issue":"6","key":"3007_CR21","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1053\/ajkd.2002.33385","volume":"39","author":"AD Salama","year":"2002","unstructured":"Salama AD, Dougan T, Levy JB, Cook HT, Morgan SH, Naudeer S, et al. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis. 2002;39(6):1162\u20137.","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"3007_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1440-1797.2011.01511.x","volume":"17","author":"XY Jia","year":"2012","unstructured":"Jia XY, Qu Z, Cui Z, Yang R, Zhao J, Zhao MH. Circulating anti-glomerular basement membrane autoantibodies against \u03b13(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays. Nephrology (Carlton). 2012;17(2):160\u20136.","journal-title":"Nephrology (Carlton)."},{"issue":"1","key":"3007_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/ndt\/gfr203","volume":"27","author":"M Mahler","year":"2012","unstructured":"Mahler M, Radice A, Sinico RA, Damoiseaux J, Seaman A, Buckmelter K, et al. Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study. Nephrol Dial Transplant. 2012;27(1):243\u201352.","journal-title":"Nephrol Dial Transplant."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-03007-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-03007-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-03007-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T23:02:59Z","timestamp":1668898979000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-03007-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3007"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-03007-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the guidelines laid down in the Declaration of Helsinki. Informed consent was obtained from the patient described in this case report, and the consent allowed their data to be stored, as required by the Hiroshima University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}